Alexander Steiner

Alexander Steiner is a seasoned professional in the biopharmaceutical industry, currently serving as the Chief Business Officer & Head of R&D Operations at ProLynx since February 2025. Prior to this role, Alexander held various leadership positions at Prellis Biologics, including Vice President & Head of Business Development and Vice President of Business Development from January 2022 to February 2025. At Sutro Biopharma, Inc., from August 2008 to January 2022, Alexander progressed from Senior Director - Business Operations & Strategy to Senior Director - Protein Biochemistry, managing business development, operational improvements, and scientific teams. Educational qualifications include an MBA in Finance and Entrepreneurial Management from The Wharton School and both a Master of Science and Bachelor of Science in Chemical Engineering from Stanford University.